Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Stability: Resistant to degradation by DPP-IV and other peptidases due to the absence of peptide bonds
Dose escalation reached 10/25 mg by week 4 and 50 mg by week 8, supporting tolerability while maintaining robust efficacy without an apparent weight-loss plateau
Images are for illustrative purposes only.
Serious but rare risks associated with tirzepatide include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal side effects), and hypersensitivity reactions
Market Forces High Competition Markets: Multiple providers in area Price competition fierce Better prices for patients $349-$499/month typical Low Competition Markets: Few providers available Less price pressure Higher prices possible $499-$699/month typical Telehealth reduces geographic barriers, increasing competition everywhere
